|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.990 JOD | -0.50% |
|
-0.50% | +24.38% |
| 07-22 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
| Market Cap | 14.92M 21.06M 18.5M 17.27M 15.85M 29.67M 2.02B 30.4M 205M 80.09M 998M 79.06M 77.34M 3.45B | P/E 2024 |
13.7x | P/E 2025 | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 14.86M 20.96M 18.42M 17.19M 15.78M 29.54M 2.01B 30.26M 204M 79.73M 994M 78.7M 76.99M 3.43B | EV / Sales 2024 |
1.32x | EV / Sales 2025 | 1.3x |
| Free-Float |
7.27% | Yield 2024 |
4.67% | Yield 2025 | - |
| 1 day | -0.50% | ||
| 1 week | -0.50% | ||
| Current month | +19.16% | ||
| 1 month | +19.16% | ||
| 3 months | +28.39% | ||
| 6 months | +25.95% | ||
| Current year | +24.38% |
| 1 week | 1.99 | 1.99 | |
| 1 month | 1.71 | 2.01 | |
| Current year | 1.5 | 2.01 | |
| 1 year | 1.46 | 2.01 | |
| 3 years | 1.35 | 2.01 | |
| 5 years | 1.28 | 2.01 | |
| 10 years | 1.28 | 3.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ashraf Hussein
CEO | Chief Executive Officer | 44 | 01/01/2013 |
Rima Shanoudeh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Belal Salameh
DFI | Director of Finance/CFO | 50 | 01/01/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Munther Hussein
CHM | Chairman | 58 | - |
| Director/Board Member | 61 | 01/09/2016 | |
| Director/Board Member | 64 | 01/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.50% | -0.50% | +35.37% | +47.41% | 21.06M | ||
| +0.56% | +2.41% | +15.42% | +75.01% | 49.85B | ||
| -1.74% | +3.57% | +56.23% | +116.36% | 36.89B | ||
| -0.54% | +5.27% | -5.96% | +24.80% | 12.43B | ||
| -0.68% | +0.12% | +12.05% | +76.37% | 11.69B | ||
| +1.05% | +0.96% | +31.25% | +132.30% | 9.04B | ||
| -1.36% | +2.46% | +47.46% | -5.54% | 7.15B | ||
| +0.17% | +0.60% | +13.68% | +31.98% | 6.7B | ||
| -3.16% | -0.67% | +1.70% | +178.01% | 6.66B | ||
| +0.61% | -3.87% | -35.09% | -1.66% | 5.45B | ||
| Average | -0.56% | +1.83% | +17.21% | +67.50% | 14.59B | |
| Weighted average by Cap. | -0.46% | +2.51% | +23.61% | +80.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.76M 12.36M 10.86M 10.14M 9.31M 17.42M 1.18B 17.85M 120M 47.02M 586M 46.41M 45.41M 2.03B | 9.17M 12.94M 11.37M 10.61M 9.74M 18.23M 1.24B 18.68M 126M 49.2M 613M 48.57M 47.51M 2.12B |
| Net income | 822K 1.16M 1.02M 951K 872K 1.63M 111M 1.67M 11.27M 4.41M 54.94M 4.35M 4.26M 190M | 1.01M 1.42M 1.25M 1.16M 1.07M 2M 136M 2.05M 13.79M 5.39M 67.22M 5.32M 5.21M 232M |
| Net Debt | 334K 471K 414K 386K 354K 663K 45.08M 680K 4.58M 1.79M 22.31M 1.77M 1.73M 77.12M | -67.69K -95.49K -83.91K -78.32K -71.88K -135K -9.15M -138K -929K -363K -4.53M -359K -351K -15.65M |
Employees
129
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/07/26 | JOD 1.990 | -0.50% | 57 |
| 22/07/26 | JOD 2.000 | -0.50% | 800 |
- Stock Market
- Stocks
- PHIL Stock
Select your edition
All financial news and data tailored to specific country editions
















